These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Aycock R Hepatology; 2000 Oct; 32(4 Pt 1):873; author reply 874-5. PubMed ID: 11041687 [No Abstract] [Full Text] [Related]
7. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine. Kurup A; San LM; Yew WS Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178 [No Abstract] [Full Text] [Related]
8. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. Stark K; Günther M; Neuhaus R; Reinke P; Schröder K; Linnig S; Bienzle U J Infect Dis; 1999 Dec; 180(6):2014-7. PubMed ID: 10558960 [TBL] [Abstract][Full Text] [Related]
9. Release potency tests of hepatitis vaccines. Descamps J; Mary A; Rommel E; Anhoury ML; De Neys R; Duchêne M Dev Biol Stand; 1999; 101():289-94. PubMed ID: 10566803 [TBL] [Abstract][Full Text] [Related]
10. Immunogenecity of hepatitis A vaccine in children below 2 years of age. Mittal SK; Rastogi A Indian Pediatr; 1999 Jan; 36(1):97. PubMed ID: 10709135 [No Abstract] [Full Text] [Related]
11. [Immunogenicity and efficacy trials of live attenuated hepatitis A vaccines]. Xu Z; Li R; Meng Z Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):254-6. PubMed ID: 10923477 [TBL] [Abstract][Full Text] [Related]
12. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines. Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755 [TBL] [Abstract][Full Text] [Related]
14. [Clinical development of a new inactivated hepatitis A vaccine]. Vidor E; Saliou P Sante; 1998; 8(5):361-8. PubMed ID: 9854014 [TBL] [Abstract][Full Text] [Related]
15. [Hepatitis A prevention by vaccination]. Busch N Dtsch Med Wochenschr; 1998 Aug; 123(33):988. PubMed ID: 9739348 [No Abstract] [Full Text] [Related]
16. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961 [TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine. Dumas R; Forrat R; Lang J; Farinelli T; Loutan L Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195 [TBL] [Abstract][Full Text] [Related]
18. WHO position paper on hepatitis A vaccines. Can Commun Dis Rep; 2000 Mar; 26(5):33-8. PubMed ID: 10769944 [No Abstract] [Full Text] [Related]